DR. RAFAEL BEJAR

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Aptose Biosciences Inc.

Filing Date Source Excerpt
2024-07-17 Named Executive Officers and Directors Dr. Rafael Bejar 123,053 Shares beneficially owned Does not exceed one percent of Shares outstanding
2024-12-30 Name of Beneficial Owner Named Executive Officers and Directors Dr. Rafael Bejar 153,254 *

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22